Wnt/glycogen synthase kinase 3β/β-catenin signaling activation mediated sevoflurane preconditioning-induced cardioprotection

Chinese Medical Journal

Volumn 128, Issue 17, 2015, Pages 2346-2353

  Liu, Jin Dong ^a   Deng, Qian ^a   Tian, Huan Huan ^a   Pang, Yun Ting ^a   Deng, Gan Lin ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cardioprotection; Ischemia reperfusion injury; Preconditioning; Sevoflurane; Wnt Glycogen synthase kinase 3 catenin Signaling

Indexed keywords

BETA CATENIN; DIMETHYL SULFOXIDE; GLYCOGEN SYNTHASE KINASE 3BETA; IWP 2; LACTATE DEHYDROGENASE; PROTEIN INHIBITOR; SEVOFLURANE; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN; ETHER DERIVATIVE; GLYCOGEN SYNTHASE KINASE 3; GSK3B PROTEIN, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART PROTECTION; HEMODYNAMIC PARAMETERS; HYPOXIA; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL HYPOXIA; CELL LINE; DRUG EFFECTS; GENETICS; HEMODYNAMICS; METABOLISM; MYOCARDIAL REPERFUSION INJURY; WISTAR RAT; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; CELL HYPOXIA; CELL LINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HEMODYNAMICS; MALE; METHYL ETHERS; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; WNT SIGNALING PATHWAY;

EID: 84940178039     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.163375     Document Type: Article

References (41)

1. Feng J, Zhu M, Schaub MC, Gehrig P, Roschitzki B, Lucchinetti E, et al.Phosphoproteome analysis of isoflurane-protected heart mitochondria: Phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function. Cardiovasc Res 2008;80:20-9
2. Dai AL, Fan LH, Zhang FJ, Yang MJ, Yu J, Wang JK, et al.Effects of sevoflurane preconditioning and postconditioning on rat myocardial stunning in ischemic reperfusion injury. J Zhejiang Univ Sci B 2010;11:267-74
3. Weber NC, Schlack W. Inhalational anaesthetics and cardioprotection. Handb Exp Pharmacol 2008;182:187-207
4. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982;31:99-109
5. Melkonyan HS, Chang WC, Shapiro JP, Mahadevappa M, Fitzpatrick PA, Kiefer MC, et al.SARPs: A family of secreted apoptosis-related proteins. Proc Natl Acad Sci U S A 1997;94:13636-41
6. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998;14:59-88
7. Smalley MJ, Dale TC. Wnt signalling in mammalian development and cancer. Cancer Metastasis Rev 1999;18:215-30
8. Patapoutian A, Reichardt LF. Roles of Wnt proteins in neural development and maintenance. Curr Opin Neurobiol 2000;10:392-9
9. Chong ZZ, Maiese K. Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. Histol Histopathol 2004;19:495-504
10. Das A, Xi L, Kukreja RC. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem 2008;283:29572-85
11. Gao HK, Yin Z, Zhou N, Feng XY, Gao F, Wang HC. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis. J Cardiovasc Pharmacol 2008;52:286-92
12. Yin H, Chao L, Chao J. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension 2004;43:109-16
13. Murphy E, Steenbergen C. Preconditioning: The mitochondrial connection. Annu Rev Physiol 2007;69:51-67
14. Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase – Dependent pathway is cardioprotective. Circ Res 2002;90:377-9
15. Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008;117:2761-8
16. Wagner C, Kloeting I, Strasser RH, Weinbrenner C. Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: Role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol 2008;52:430-7
17. Shin EJ, Schram K, Zheng XL, Sweeney G. Leptin attenuates hypoxia/reoxygenation-induced activation of the intrinsic pathway of apoptosis in rat H9c2 cells. J Cell Physiol 2009;221:490-7
18. Conacci-Sorrell M, Zhurinsky J, Ben-Ze’ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-91
19. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36
20. Kloner RA, Bolli R, Marban E, Reinlib L, Braunwald E. Medical and cellular implications of stunning, hibernation, and preconditioning: An NHLBI workshop. Circulation 1998;97:1848-67
21. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: Evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005;102:102-9
22. Pagel PS, Krolikowski JG, Neff DA, Weihrauch D, Bienengraeber M, Kersten JR, et al.Inhibition of glycogen synthase kinase enhances isoflurane-induced protection against myocardial infarction during early reperfusion in vivo. Anesth Analg 2006;102:1348-54
23. Krolikowski JG, Weihrauch D, Bienengraeber M, Kersten JR, Warltier DC, Pagel PS. Role of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo. Can J Anaesth 2006;53:174-82
24. Cavallo RA, Cox RT, Moline MM, Roose J, Polevoy GA, Clevers H, et al.Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature 1998;395:604-8
25. Roose J, Molenaar M, Peterson J, Hurenkamp J, Brantjes H, Moerer P, et al.The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 1998;395:608-12
26. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997;16:3797-804
27. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-80
28. Park M, Youn B, Zheng XL, Wu D, Xu A, Sweeney G. Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis. PLoS One 2011;6:e19143
29. Barandon L, Dufourcq P, Costet P, Moreau C, Allières C, Daret D, et al.Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning. Circ Res 2005;96:1299-306
30. Mirotsou M, Zhang Z, Deb A, Zhang L, Gnecchi M, Noiseux N, et al.Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A 2007;104:1643-8
31. Li F, Chong ZZ, Maiese K. Winding through the WNT pathway during cellular development and demise. Histol Histopathol 2006;21:103-24
32. Loh YN, Hedditch EL, Baker LA, Jary E, Ward RL, Ford CE. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer. BMC Cancer 2013;13:174
33. Knabb MT, Danielsen CA, McShane-Kay K, Mbuy GK, Woodruff RI. Herpes simplex virus-type 2 infectivity and agents that block gap junctional intercellular communication. Virus Res 2007;124:212-9
34. Hopper RA, Forrest CR, Xu H, Zhong A, He W, Rutka J, et al.Role and mechanism of PKC in ischemic preconditioning of pig skeletal muscle against infarction. Am J Physiol Regul Integr Comp Physiol 2000;279:R666-76
35. Inagaki K, Begley R, Ikeno F, Mochly-Rosen D. Cardioprotection by epsilon-protein kinase C activation from ischemia: Continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation 2005;111:44-50
36. Minatoguchi S, Uno Y, Kariya T, Arai M, Wang N, Hashimoto K, et al.Cross-talk among noradrenaline, adenosine and protein kinase C in the mechanisms of ischemic preconditioning in rabbits. J Cardiovasc Pharmacol 2003;41 Suppl 1:S39-47
37. Milano G, Morel S, Bonny C, Samaja M, von Segesser LK, Nicod P, et al.A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo. Am J Physiol Heart Circ Physiol 2007;292:H1828-35
38. Wang J, Yang L, Rezaie AR, Li J. Activated protein C protects against myocardial ischemic/reperfusion injury through AMP-activated protein kinase signaling. J Thromb Haemost 2011;9:1308-17
39. Bao W, Hu E, Tao L, Boyce R, Mirabile R, Thudium DT, et al.Inhibition of Rho-kinase protects the heart against ischemia/ reperfusion injury. Cardiovasc Res 2004;61:548-58
40. Zhang J, Li XX, Bian HJ, Liu XB, Ji XP, Zhang Y. Inhibition of the activity of Rho-kinase reduces cardiomyocyte apoptosis in heart ischemia/reperfusion via suppressing JNK-mediated AIF translocation. Clin Chim Acta 2009;401:76-80
41. Lipton SA, Bossy-Wetzel E. Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Cell 2002;111:147-50.